FindTrial
Sign In

IgG-subclass and/or antipolysaccharide antibody deficiency.

IgG-subclass and/or antipolysaccharide antibody deficiency. - IGG-2009-2010

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON39742
Enrollment
Unknown
Registered
2008-09-03
Start date
2009-01-01
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary immunodeficiency

Interventions

None listed

Sponsors

Interfacultaire Werkgroep Immuundeficiënties (WID)
Lead Sponsor

Eligibility

Age
2 Years to 17 Years

Inclusion criteria

Inclusion criteria: >= 2 and = 4,0 g/l IgG-subclass (IgG1, IgG2, and/or IgG3) and/or antipolysaccharide antibody deficiency

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

MeasureTime frame
The diagnosis of IgG-subclass and/or antipolysaccharide antibodydeficiency.—

Secondary

MeasureTime frame
Information about the diagnostic process, the clinical presentation, therapies, and prognosis.—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)